SOHO Brazil 2022

https://rvmais.iweventos.com.br/site/sintoma2022

 

SOHO Brazil 2022
H

SOHO Brazil 2022: My Low-Risk MDS Patient With Ring Sideroblasts Is Losing Response to Erythropoietin - What to do?

By SOHO Brazil 2022 FEATURING Hetty Carraway, Phillip Scheinberg
By SOHO Brazil 2022 FEATURING Hetty Carraway, Phillip Scheinberg
43 views
August 31, 2022
Comments 0
Login to view comments. Click here to Login

Featured Video

19:39
Pfizer Hematology

The First Treatment Choice Matters

Feat. A. Ip

Featured Video

18:30
Pfizer Hematology

Expert Case Review: A Treatment Option for Adult Patients With Stage…

Feat. A. Whiteley
MDS
26:42

SOHO Brazil 2022: When Low-Risk MDS Behaves Badly

SOHO Brazil 2022

A. Zeidan, P. Scheinberg

10 views
29:02

SOHO Brazil 2022: My Low-Risk MDS Patient With Ring Sideroblasts Is …

SOHO Brazil 2022

H. Carraway, P. Scheinberg

43 views
20:09

SOHO Brazil 2022: How Is the Great Barrier of Highly-Resistant Myelo…

SOHO Brazil 2022

A. Zeidan, P. Scheinberg

10 views
27:44

SOHO Brazil 2022 on MDS: Get to Know the IPSS-M & Other Molecularly-…

SOHO Brazil 2022

M. Sekeres, P. Scheinberg

46 views
29:49

SOHO Brazil 2022: Bringing AML Approaches to High-Risk MDS - Is It W…

SOHO Brazil 2022

A. Zeidan, P. Scheinberg

65 views